Related Experiment Video

Updated: Jul 29, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

E2F4 deficiency promotes drug-induced apoptosis

Yihong Ma1, Scott N Freeman, W Douglas Cress

  • 1Molecular Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida College of Medicine, Tampa, Florida 33612-9497, USA.

Cancer Biology & Therapy
|December 22, 2004
PubMed

Insights

The study reveals that E2F4 promotes resistance to apoptosis, while E2F1 enhances cell death. Manipulating these transcription factors impacts sensitivity to chemotherapy and kinase inhibitors.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • E2F1 and E2F4 are transcription factors known to have opposing roles in cell cycle regulation.
  • Understanding their roles in apoptosis is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To investigate the roles of E2F1 and E2F4 in apoptosis induced by cyclin-dependent kinase inhibitors and chemotherapeutic drugs.
  • To determine how the expression levels of E2F1 and E2F4 are affected by these treatments.
  • To assess the impact of E2F4 and E2F1 deficiency on drug-induced apoptosis.

Main Methods:

  • Treatment of mouse fibroblasts and human cancer cells with cyclin-dependent kinase inhibitors (roscovitine, BMS-387032, flavopiridol) and chemotherapeutic drugs (VP16, cisplatin, paclitaxel).
  • Analysis of E2F1 and E2F4 protein levels following drug treatment.
  • Assessment of apoptosis in E2F4-null and E2F1-deficient mouse fibroblasts.
  • Evaluation of drug sensitivity in human cancer cells with RNAi-mediated reduction of E2F4.

Main Results:

  • Cyclin-dependent kinase inhibitors and DNA-damaging drugs decreased E2F4 levels and increased E2F1 levels.
  • E2F4-deficient fibroblasts showed increased sensitivity to apoptosis induced by the tested drugs.
  • E2F1-deficient fibroblasts exhibited decreased sensitivity to drug-induced apoptosis.
  • Reduced E2F4 levels in human cancer cells via RNAi led to increased sensitivity to these drugs.

Conclusions:

  • E2F1 and E2F4 play opposing roles in drug-induced apoptosis.
  • E2F4 acts as a suppressor of apoptosis, while E2F1 promotes it.
  • Targeting E2F4 or E2F1 could be a therapeutic strategy to enhance cancer treatment efficacy.

More Related Videos

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells08:47

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells

Published on: May 1, 2020

Comprehensive Analysis of Drug Response using the FLICK Assay09:42

Comprehensive Analysis of Drug Response using the FLICK Assay

Published on: June 6, 2025

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...